Metabolite acetyl-L-carnitine participates in Bifidobacterium animalis F1-7 to ameliorate atherosclerotic inflammation by downregulating theTLR4/NF-κB pathway

Metabolite acetyl-L-carnitine participates in Bifidobacterium animalis F1-7 to ameliorate atherosclerotic inflammation by downregulating theTLR4/NF-κB pathway

This study aimed to explore the effect of Bif idobacterium animalis F1-7 on the improvement of atherosclerotic inflammation. Arteriosclerosis model ApoE-/- mice were orally administered with B. animalis F1-7 for 12 weeks. The probiotic intervention reduced the plaque areas in aorta and the accumulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xi Liang, Zhe Zhang, Xiaoying Tian, Qingyu Cui, Haiyan Lu, Maozhen Zhao, Tongjie Liu, Huaxi Yi, Pimin Gong, Lanwei Zhang
Format: Article
Language:English
Published: Tsinghua University Press 2024-03-01
Series:Food Science and Human Wellness
Subjects:
bifidobacterium animalis f1-7
atherosclerosis
inflammation
metabonomics
acetyl-l-carnitine
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2022.9250069
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.sciopen.com/article/10.26599/FSHW.2022.9250069

Similar Items